Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 20:42:05 02/10/2026 BST			5-day change	1st Jan Change
257.00 ^EUR	-1.65%		-1.28%	+48.27%

09-30	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
09-29	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
WUXI APPTEC CO., LTD.	74.41B		AAA
ARGENX SE	59.26B		A
LONZA GROUP AG	47.14B		AAA
IQVIA HOLDINGS INC.	42.91B		AAA
REVOLUTION MEDICINES, INC.	44.13B	-	B	-	-
BEONE MEDICINES AG	40.79B		-
CELLTRION, INC.	30.77B		A
WUXI BIOLOGICS (CAYMAN) INC.	29.31B		AAA
INSMED INCORPORATED	23.71B	-	BBB	-	-
BIONTECH SE	24.33B	-	-	-	-
GENMAB A/S	20.81B		A
MEDPACE HOLDINGS, INC.	16.69B		BBB
PHARMAESSENTIA CORPORATION	15.17B		AA
ASCENDIS PHARMA A/S	14.93B	-	-	-	-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	14.84B		AA
EUROFINS SCIENTIFIC SE	14.57B		AA
TEMPUS AI, INC.	13.8B		A		-
EXELIXIS, INC.	14.36B		BB
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.69B		AA
Average	29.24B		AA
Weighted average by Cap.			AA